Topas Therapeutics GmbH
Location: Germany, Hamburg
Total raised: $63.15M
Investors 3
| Date | Name | Website |
| - | Vesalius B... | vesaliusbi... |
| 16.06.2022 | GIMV | gimv.com |
| - | Epidarex C... | epidarex.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.07.2021 | Series B | $47.49M | - |
| 23.03.2016 | Series A | $15.66M | - |
Mentions in press and media 13
| Date | Title | Description |
| 15.10.2024 | Topas Therapeutics Announces Positive Topline Results from Phase 2a Trial | - |
| 29.07.2021 | Topas Therapeutics GmbH : Extends Series B, Raising Total of ?40 Million (~$ 48 Million) in this Round | DGAP-News: Topas Therapeutics GmbH / Key word(s): Financing Topas Therapeutics Extends Series B, Raising Total of ?40 Million (~$ 48 Million) in this Round 29.07.2021 / 09:00 The issuer is solely responsible for the content of this announce... |
| 29.07.2021 | Evotec : spin-off Topas Therapeutics extends Series B, raising total of 40 m (~ $ 48 m) in this Round | Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases Initial clinical data for lead program, TPM20... |
| 29.07.2021 | PRESS RELEASE : Topas Therapeutics Extends Series B, Raising Total of EUR40 Million (USD 48 Million) in this Round | DGAP-News: Topas Therapeutics GmbH / Key word(s): Financing Topas Therapeutics Extends Series B, Raising Total of EUR40 Million (USD 48 Million) in this Round 2021-07-29 / 09:00 The issuer is solely responsible for the content of this annou... |
| 29.07.2021 | Evotec : spin-off Topas Therapeutics extends Series B, raising total of 40 Million (~$48 Million) in this Round | Evotec spin-off Topas Therapeutics extends Series B, raising total of €40 Million (~$48 Million) in this Round Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring i... |
| 29.07.2021 | Evotec : spin-off Topas Therapeutics extends Series B, raising total of 40 m (~$ 48 m) in this round | Evotec spin-off Topas Therapeutics extends Series B, raising total of € 40 m (~$ 48 m) in this round Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tole... |
| 29.07.2021 | Gimv : Topas Therapeutics announces and extended Series B round with an additional 18 million (± $ 22 million) | Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases Initial clinical data for lead program, TPM20... |
| 27.07.2021 | Topas Therapeutics Extends Series B, Raising Total of €40 Million (~$ 48 Million) in this Round | - |
| 27.07.2021 | Topas Therapeutics Extends Series B, Raising Total of €40 Million (~$ 48 Million) | - |
| 19.10.2020 | Topas Therapeutics Raises €22 Million (~USD 26 Million) in Series B Financing | - |
Show more